Terumo Corporation is a major player in the global Healthcare sector, specializing in medical instruments and supplies. With a significant market capitalization of 3.31 Trillion JPY, the company holds a prominent position in its industry. Terumo is known for its wide range of medical devices, from hospital care products to complex cardiovascular systems, serving healthcare providers worldwide.

The current technical analysis for Terumo Corporation results in a Sell rating with a total score of -2. This assessment is primarily driven by the long-term trend indicator. The current price of JPY2,245.00 is trading below its 200-day Simple Moving Average (JPY2,271.51), contributing a heavily weighted score of -2. Furthermore, the MACD histogram is negative, confirming bearish momentum with a score of -1. While the RSI at 50.70 is neutral and the ADX at 18.02 indicates a weak trend, these do not provide any bullish counter-signals. A minor positive sign comes from the On-Balance Volume (OBV), which is slightly above its short-term average, suggesting some recent accumulation, but it is insufficient to overcome the dominant bearish trend signals.

In conclusion, the technical indicators suggest a cautious or bearish outlook. When compared with the company's fundamentals, the picture is mixed. The P/E ratio of 24.37 suggests the stock is not undervalued, which aligns with the technical weakness. The provided dividend yield is an exceptionally high 162.0, a figure that investors should verify. Critically, there is no recently reported EPS data, and the next earnings report is not scheduled until 06/08/2026. This lack of recent earnings performance data creates uncertainty, making the bearish technical signals the most actionable information available for short-term traders at this moment.